Treatment Group | Individual tank final CPMa | Ave. final CPM | Mean day to death±SDb | Day 7 infection, # pos/# tested (# > inoculum)c |
---|---|---|---|---|
Experiment 1 | ||||
wt VHSVmi | 6, 0, 12 | 6 | 13.5* | 8/9 (5) |
rVHSVmi | 0, 0, 12 | 4 | 19* | 7/9 (3) |
rVHSVmi-Gdk | 12, 0, 6 | 6 | 14.5* | 2/9 (0) |
rVHSVmi-NVdk | 0, 24, 6 | 10 | 11.6* | 6/9 (3) |
rVHSVmi-GNVdk | 6, 0, 6 | 4 | 12.5* | 4/9 (2) |
wt VHSVdk | 100 | 100 | 4.6* | nt |
rVHSVdk | 100, 100, 100 | 100 | 4.9 ± 0.20 | nt |
rVHSVdk-Gmi | 100, 100, 100 | 100 | 5.2 ± 0.20 | nt |
rVHSVdk-NVmi | 100, 100, 100 | 100 | 4.6 ± 0.28 | nt |
rVHSVdk-GNVmi | 100, 100, 100 | 100 | 4.1 ± 0.15 | nt |
mock | 0, 0 | 0 | na | 0/6 |
Experiment 2 | ||||
wt VHSVmi | 0 | 0 | na | nt |
rVHSVmi | 0, 6, 6 | 4 | 8.5* | 3/9 (3) |
rVHSVmi-Gdk | 0, 0 | 0 | na | 2/6 (1) |
rVHSVmi-GNVLdk | 0, 12, 0 | 0 | 14.5* | 3/9 (3) |
wt VHSVdk | 100 | 100 | 3.5* | nt |
rVHSVdk | 100, 100, 95 | 98 | 5.0 ± 0.34 | nt |
rVHSVdk-Gmi | 100, 100 | 100 | 5.1* | nt |
rVHSVdk-GNVLmi | 100, 100, 100 | 100 | 4.64 ± 0.27 | nt |
mock | 0, 0, 0 | 0 | na | 0/9 |